Trials / Completed
CompletedNCT00280605
ALF-ONE : ALFuzosin ONcE Daily
Study of the Outcome of Patients With Lower Urinary Symptoms Suggestive of Benign Prostatic Hyperplasia and Treated With Alfuzosin 10 mg Once Daily for 3 Months in China
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to collect, under daily practice conditions, clinical data on the safety profile and the efficacy of a new formulation of alfuzosin administered once daily in patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alfuzosin |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2006-02-01
- Completion
- 2006-02-01
- First posted
- 2006-01-23
- Last updated
- 2010-08-31
Source: ClinicalTrials.gov record NCT00280605. Inclusion in this directory is not an endorsement.